Tag Archives: Baxter

Baxter Receives Third FDA Warning for Misleading Promotional Material

By Julian Upton | Published: September 1, 2010
FDA issued a warning letter to Baxter International for making “misleading efficacy claims” about its lung drug Araplast NP, which is contraindicated in individuals with selective IgA deficiencies and prescribed to patients who are at increased risk of emphysema. FDA’s letter, dated Aug. 3, takes issue with claims in a brochure aimed at physicians that [...]
Posted in FDA | Also tagged , , , , | Leave a comment

Is a Swine Flu Vaccine Backlash on the Cards?

By Julian Upton | Published: July 23, 2009
Image by The Artifex via Flickr The risk of over-production has paid off: world orders for swine vaccines will see billions of dollars in extra revenue for the biggest pharma companies. GlaxoSmithKline, Roche, Sanofi-Aventis, Novartis, and Baxter are all expected to report very healthy first-half earnings as a result of a wealth of government contracts for [...]
Posted in Global, News | Also tagged , , , , , , | 1 Comment